Dopamine versus norepinephrine in the treatment of cardiogenic shock: A PRISMA-compliant meta-analysis.

about

Dopamine versus norepinephrine in the treatment of cardiogenic shock: A PRISMA-compliant meta-analysis.

Item

http://www.wikidata.org/entity/Q45718827

description

2017 nî lūn-bûn

@nan

2017 թվականի հոկտեմբերին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

Dopamine versus norepinephrine ...... RISMA-compliant meta-analysis.

@en

Dopamine versus norepinephrine ...... RISMA-compliant meta-analysis.

@nl

type

Item

label

Dopamine versus norepinephrine ...... RISMA-compliant meta-analysis.

@en

Dopamine versus norepinephrine ...... RISMA-compliant meta-analysis.

@nl

prefLabel

Dopamine versus norepinephrine ...... RISMA-compliant meta-analysis.

@en

Dopamine versus norepinephrine ...... RISMA-compliant meta-analysis.

@nl

P1476

Dopamine versus norepinephrine ...... PRISMA-compliant meta-analysis

@en

P2093

Huajia Yang

http://www.w3.org/2001/XMLSchema#string

Min Chen

http://www.w3.org/2001/XMLSchema#string

Nannan Zhang

http://www.w3.org/2001/XMLSchema#string

Qing Rui

http://www.w3.org/2001/XMLSchema#string

Yafeng Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Scandinavian SSAI clinical practice guideline on choice of first-line vasopressor for patients with acute circulatory failure

Trends in the management and outcomes of patients admitted with acute coronary syndrome complicated by cardiogenic shock over the past decade: Real world data from the acute coronary syndrome Israeli survey (ACSIS).

Cardiogenic shock: current concepts and improving outcomes.

Vasoactive drugs in circulatory shock.

Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias.

Pharmacologic therapies for acute cardiogenic shock.

Acute mechanical circulatory support for cardiogenic shock: the "door to support" time

Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock.

Temporal trends in the epidemiology, management, and outcome of patients with cardiogenic shock complicating acute coronary syndromes.

P304

e8402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1097/MD.0000000000008402

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yu-Feng Jiang

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29069037

http://www.w3.org/2001/XMLSchema#string

P921

norepinephrine

cardiogenic shock

P932

5671870

http://www.w3.org/2001/XMLSchema#string